Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
Time for a Digital Revolution in the Women’s Health Market
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI
* Required Fields
Pay by invoice
With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for industry participants to leverage. Capital flow has grown dramatically in biotech due to emergence of start-ups and small/midsize biotech having advanced techniques involved in next-generation therapies, such as immunotherapies and personalized medicines. In the biopharma sector, companies with platform technology for targeting multiple indications in early clinical and preclinical stages, such as Roviant Sciences, Curevac, and Sana Biotechnology saw the highest investments in 2020.This report reviews the significant drivers that will propel the VC investment in biotech and specifically CGT. It highlights the dynamics of the Chinese investors in the biotech VC landscape.Other discussions on the biotech VC investment trend include:• The healthcare sector VC landscape in the US and EU from 2018 to 2020.• Key trends in biopharma VC investment.• Analysis of global biotech VC deals by modality from 2016 to H1 2021.• Analysis of global biotech VC deals by therapeutic segment from 2016 to H1 2021.• Analysis of global biotech VC deals by stage of clinical development from 2016 to H1 2021.• A snapshot of the VC investment trend in the CGT segment.• The key companies to watch in the CGT space.• Key growth opportunities paving the way for future VC investment in the biotech industry.Author: Surbhi Gupta
Global Pharmaceutical Industry Growth Opportunities
Targeted Immunotherapy in Oncology
EU COVID-19 Vaccine and Therapeutics Insights, Trends, and Growth Opportunities
Technological Advances in RNA Stabilization & Delivery
Global Pharmaceutical Packaging Growth Opportunities
Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities
Post-COVID-19 Trends Disrupt the Global Contract Research Organization (CRO) Market
US COVID-19 Vaccines and Therapeutics Tracker—Market Insights and Trends, H1 2021
Regulatory and Infrastructure Reforms in India and China Catalyzing the Asian Specialty Generics Market
I-O Therapy Combinations Spurring Growth of the Global Immuno-oncology Market
smart grid market
virtual reality market
smart wearables market
cardiovascular devices market
plastic waste management market
smart meter market
glucose monitoring devices market
consumer electronics market
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.